Mineralys Therapeutics, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 1.31 | 1.32 | 1.09 | 1.17 | 1.50 | 0.50 | 0.30 | 0.56 | 0.59 | 0.68 | 0.80 | 1.08 | 0.89 | 0.71 | 0.58 | 0.45 | 0.30 | 0.29 | 2.61 | 3.56 | |
| 0.09 | 0.15 | 0.17 | 0.26 | 0.42 | 0.11 | 0.10 | 0.09 | 0.10 | 0.10 | 0.12 | 0.12 | 0.14 | 0.12 | 0.13 | 0.14 | 0.17 | 0.25 | 0.29 | 0.82 | |
| 1.40 | 1.48 | 1.26 | 1.43 | 1.92 | 0.60 | 0.40 | 0.66 | 0.69 | 0.79 | 0.92 | 1.21 | 1.04 | 0.84 | 0.71 | 0.58 | 0.48 | 0.55 | 2.90 | 4.38 | |
| -1.40 | -1.48 | -1.26 | -1.43 | -1.92 | -0.60 | -0.40 | -0.66 | -0.69 | -0.79 | -0.92 | -1.21 | -1.04 | -0.84 | -0.71 | -0.58 | -0.48 | -0.55 | -2.90 | -4.38 | |
| 0.00 | – | – | – | 0.32 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.40 | -1.48 | -1.26 | -1.29 | -1.74 | -0.51 | -0.31 | -0.57 | -0.61 | -0.70 | -0.83 | -1.13 | -0.98 | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 | -4.13 | |
| -1.40 | -1.48 | 0.00 | 0.00 | 0.00 | – | -0.09 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| -1.40 | -1.48 | -1.26 | -1.29 | -1.74 | -0.51 | -0.31 | -0.57 | -0.61 | -0.70 | -0.83 | -1.13 | -0.98 | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 | -4.13 | |
| -1.40 | -1.48 | -1.26 | 0.14 | 0.18 | -0.51 | -0.31 | -0.57 | -0.61 | -0.70 | -0.83 | -1.13 | -0.98 | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 | -4.13 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.